<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Clinical trials and investigational tests</p><p class="Section" id="234273"><strong><a class="sectionLabel" id="s-21.71"><span class="sectionLabel">21.71</span></a></strong> The holder of a therapeutic product authorization referred to in paragraph 30(1.2)(c) shall ensure that prescribed information concerning the clinical trial or investigational test is made public within the prescribed time and in the prescribed manner.</p><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">2014, c. 24, s. 3</li><li class="HistoricalNoteSubItem">2019, c. 29, s. 168(F)</li></ul></div>